
11 Nov 2024
Syensqo COMPAMED 2024 press kit
Syensqo, previously part of Solvay Group, will attend COMPAMED 2024 where they will be highlighting their broad selection of medical-grade thermoplastics, specifically designed for implantables, medical devices, and equipment.
Press Releases
Syensqo to showcase advanced portfolio of medical-grade polymers at Compamed
Syensqo, previously part of Solvay Group and a leading global provider of advanced performance materials and chemical solutions, is making its debut at Compamed 2024. Visitors will be able to explore the company’s full range of high-performance polymers for the healthcare and pharmaceuticals industry, including an advanced portfolio of Solviva® biomaterials for implantable medical devices.
Syensqo is born following overwhelming support of shareholders on demerger of Solvay
As the Extraordinary General Shareholders’ Meeting of Solvay SA/NV closed today with massive support (+99.53%) of shareholders, Syensqo SA/NV will be officially demerged from Solvay effective at midnight.
Reader enquiries
Syensqo
Rue de la Fusée 98
1130 Brussels
Belgium
Notes for editors
About Syensqo
Syensqo is a science company developing groundbreaking solutions that enhance the way we live, work, travel and play. Inspired by the scientific councils which Ernest Solvay initiated in 1911, we bring great minds together to push the limits of science and innovation for the benefit of our customers, with a diverse, global team of more than 13,000 associates in 30 countries.
Our solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices and healthcare applications. Our innovation power enables us to deliver on the ambition of a circular economy and explore breakthrough technologies that advance humanity.
Learn more at www.syensqo.com.
Related images